Recommended
product-img
  • Products
  • Discover MP Targets
  • Discover Research Areas
  • mProX™ Human TTK Stable Cell Line

    [CAT#: S01YF-1023-PY124]
    Product Category:
    Membrane Protein Stable Cell Lines
    Subcategory:
    Kinase Cell Lines

    Datasheet MSDS Request COA

    Certificate of Analysis Lookup
    To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
    Lot Number

    Made to Order Inquiry

    Inquiry
    Host Cell Type:
    Membrane Protein Engineering:
    Fluorescent Marker:
    Resistance:
    Deliverable:

    Based on this stable cell line, we also provide cell-based in vitro assays to evaluate the effects of your compounds or antibodies.

    Sub Cat Product Name Target Protein Species Host Cell Type Assay Types Inquiry Datasheet
    S01YF-1222-KX519 Magic™ Human TTK in Vitro Assay Human Kinase Assay

    Product Information

    Target Family
    Kinases/Enzyme
    Target Protein Species
    Human
    Host Cell Type
    HEK293;CHO-K1;HGC-27
    Target Classification
    Kinase Cell Lines
    Target Research Area
    Cancer Research
    Related Diseases
    Pancreatic Cancer; Lung Cancer
    Gene ID
    Human:7272
    UniProt ID
    Human:P33981

    Product Properties

    Biosafety Level
    Level 1
    Activity
    Yes
    Quantity
    10⁶ cells per vial
    Applications
    TTK, also known as MPS1, is a dual-specificity protein kinase involved in the spindle assembly checkpoint, ensuring the proper segregation of chromosomes during cell division. In the scientific arena, TTK has been recognized for its role in maintaining genomic stability. Aberrant TTK expression has been associated with various cancers, including breast and lung cancers. Elevated TTK levels have been linked to poor prognosis in cancer patients, making it a potential prognostic marker. Moreover, due to its critical role in cell division, TTK has emerged as a promising therapeutic target for cancer treatment. Inhibitors targeting TTK have shown potential in preclinical studies, underscoring the kinase's significance in cancer biology and therapeutics.

    Protocols

    Please visit our protocols page.

    Customer Reviews

    There are currently no Customer reviews or questions for mProX™ Human TTK Stable Cell Line (S01YF-1023-PY124). Click the button above to contact us or submit your feedback about this product.

    FAQ

    chat Casey Jones (Verified Customer)

    Can TTK inhibitors enhance the treatment of glioblastoma? Feb 20 2021

    chat Patrick Liam (Creative Biolabs Scientific Support)

    Yes, TTK inhibitors can potentially improve the treatment of glioblastoma by overcoming resistance to drugs like t*moz*lo*ide. Feb 20 2021

    chat Skyler Johnson (Verified Customer)

    What is the role of TTK in psoriatic arthritis? Oct 03 2023

    chat Patrick Liam (Creative Biolabs Scientific Support)

    Selective TYK2 inhibitors, which target pathways involving TTK, have shown efficacy in improving symptoms in patients with psoriatic arthritis. Oct 03 2023

    Published Data

    Fig.1 Enhanced growth of gastric cancer cells is facilitated by the ectopic expression of TTK.

    A colony assay was conducted, and the colony number was determined following transfection with or without Flag-TTK. The data points were plotted as the mean ± SD of triplicate assays in all panels. Means ± SD of triplicate assays were utilized, and one-way ANOVA with Dunnett's multiple comparisons test was employed for data analysis. A scale bar of 10 μm in length was provided.

    Ref: Huang, Hongxia, et al. "TTK regulates proliferation and apoptosis of gastric cancer cells through the Akt-mTOR pathway." FEBS open bio 10.8 (2020): 1542-1549.

    Pubmed: 32530571

    DOI: 10.1002/2211-5463.12909

    Research Highlights

    Lukasczyk, Jonas. et al. "ExTreeM: Scalable Augmented Merge Tree Computation via Extremum Graphs." IEEE transactions on visualization and computer graphics, 2023.
    In recent years, merge trees have become a popular method for visualizing and analyzing complex datasets due to their effectiveness in simplifying the data. This paper presents the ExTreeM-Algorithm, a scalable approach for computing merge trees using extremum graphs. The algorithm first computes the extremum graph G for an input scalar field f defined on a cell complex K, and then derives the unaugmented merge tree for f on G. This results in faster computation times as G typically has fewer cells than K. To further speed up the process, ExTreeM includes a specialized procedure for computing merge trees on extremum graphs. A fully augmented merge tree, or a merge tree domain segmentation of K, can also be obtained in a separate post-processing step. All steps of the ExTreeM algorithm can be executed efficiently in parallel and its correctness is formally proven. The algorithm is tested on various publicly available datasets and demonstrates a significant improvement in speed, requiring less memory and showing strong scaling behavior compared to existing algorithms in TTK and VTK-m software libraries.
    Lukasczyk, Jonas. et al. "ExTreeM: Scalable Augmented Merge Tree Computation via Extremum Graphs." IEEE transactions on visualization and computer graphics, 2023.
    Pubmed: 37871087   DOI: 10.1109/TVCG.2023.3326526

    Sebák, Fanni, et al. "Assignment of the disordered, proline-rich N-terminal domain of the tumour suppressor p53 protein using 1HN and 1Hα-detected NMR measurements." Biomolecular NMR Assignments (2023): 1-6.
    The protein p53 has a significant role in the suppression of tumors and is well-known for its importance in this area. Studies have revealed that mutations in the p53 gene are frequently observed during oncogenic transformation. Researchers are continuously conducting studies to identify methods for targeting disordered proteins and protein regions in order to develop effective cancer therapies. However, obtaining atomic level information is crucial for these studies. The N-terminal region of p53 is especially challenging to analyze due to its high content of proline residues, including repetitive Pro-Ala motifs, which lack amide protons in the 1H-NMR spectrum.
    Sebák, Fanni, et al. "Assignment of the disordered, proline-rich N-terminal domain of the tumour suppressor p53 protein using 1HN and 1Hα-detected NMR measurements." Biomolecular NMR Assignments (2023): 1-6.
    Pubmed: 37861971   DOI: 10.1007/s12104-023-10160-4

    Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR CLINICAL PROCEDURES" For licensing inquiries, please contact
    Send Inquiry Send Inquiry
    Inquiry Basket
    compare

    Go to compare